Response of recurrent anaplastic ependymoma to a combination of tamoxifen and isotretinoin

Neurology

Volumn 61, Issue 7, 2003, Pages 1019-1020

  Rojas Marcos, I ^a   Calvet, D ^a   Janoray, P ^b   Delattre, Jean Yves ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Centre d oncologie du Parc polyclinique Drevon   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CARMUSTINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ISOTRETINOIN; METHYLPREDNISOLONE; PROTEIN KINASE INHIBITOR; TAMOXIFEN; TEMOZOLOMIDE; VINCRISTINE;

ADULT; ANAPLASTIC EPENDYMOMA; ARTICLE; BLOOD TOXICITY; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; EPENDYMOMA; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0141890081     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000082384.15848.fa     Document Type: Article

References (7)

1. Gornet MK, Buckner JC, Marks RS. Chemotherapy for advanced CNS ependymoma. J Neurooncol 1999;45:61-67.
2. Bouffet E, Foreman N. Chemotherapy for intracranial ependymomas. Childs Nerv Syst 1999;15:563-570.
3. Duffner PK, Krischer JP, Sanford RA. Prognostic factors in infants and very young children with intracranial ependymomas. Pediatr Neurosurg 1998;28:215-222.
4. Soffietti R, Costanza A, Nobile M, et al. Does ependymoma respond to temozolomide chemotherapy? Neurology 2001;56(suppl 3):A409.
5. Couldwell WT, Hinton DR, Surnock AA, et al. Treatment of recurrent malignant gliomas with chronic oral high dose tamoxifen. Clin Cancer Res 1996;2:619-622.
6. Weyl Ben Arush M, Postovsky S, Goldsher D, et al. Clinical and radiographic response in three children with recurrent malignant cerebral tumors with high-dose tamoxifen. Pediatr Hematol Oncol 1999;16:245-250.
7. Kaba SE, Kyristsis AP, Conrad C, et al. The treatment of recurrent cerebral gliomas with all-trans-retinoic acid (tretinoin). J Neurooncol 1997;34:145-151.